If you have any questions, please contact us.
Illicit drug use is a serious concern for all Canadians. In the 2007 Federal Budget, the Government of Canada announced the National Anti-Drug Strategy (NADS) with a goal of improving the health, safety and security of Canadians by addressing both the demand for and supply of illicit drugs in Canada. Building on existing drug-related initiatives, NADS enhances collaboration and strong working partnerships between federal, provincial and territorial governments, non-government organizations and communities.
The government supports community-level action through Health Canada's Drug Strategy Community Initiatives Fund (DSCIF). DSCIF is an on-going contribution program established in 2004 with an annual budget of $9.6 million. The DSCIF contributes to reducing illicit drug use among youth aged 10 to 24. DSCIF facilitates the development of local, provincial, territorial, national and community-based solutions for illicit drug use among youth.
Since the announcement of NADS, the DSCIF has issued two Calls for Proposals (CFP) and has signed 103 multi-year contribution agreements across Canada representing approximately $40M in investments. For the current Call for Proposals, a rigorous assessment process will be used to fund a select number of evidenced-based, multi-year, health promotion and prevention projects that will ultimately provide Canadians with information and tools to make healthy life choices.
Abuse of pharmaceutical drugs has emerged as a leading health and safety issue in Canada, marked by steep increases in rates of consumption, addiction, and death due to overdose. For example, the 2012 Canadian Alcohol and Drug Use Monitoring Survey shows that Canadian consumption of prescribed opioid drugs has risen by over 200% since 2000. Prescription drugs are now the third most commonly abused substance among Canadian youth, after alcohol and marijuana. Canadians do not have a strong understanding of the risks and dangers associated with prescription drugs.
Prescription drug abuse is damaging to Canadian families and communities. Among the most commonly abused prescription drugs are opioids such as oxycodone, fentanyl and morphine. As part of the Government's comprehensive approach to addressing prescription drug abuse, Health Canada is consulting on proposed regulations that would require that drugs at high risk for abuse, like controlled-release oxycodone, have tamper-resistant properties before they can be sold in Canada. But, requiring tamper-resistant formulations of drugs is only one component of the comprehensive approach required to effectively tackle prescription drug abuse. One area in particular that has been identified for improvement is prescriber practices. Improved prescriber education will support appropriate prescriber practices.
Under the Drug Strategy Community Initiatives Fund (DSCIF), Health Canada is issuing this Call for Proposals to improve prescriber education through the development of guidelines, training and tools. The proposal can address one or more of the following classes of prescription drugs: opiates/opioids, tranquillizers/sedatives and stimulants.
We have identified two priority areas:
Proposals are expected to be national in scope involving a broad range of national and jurisdictional stakeholders who can represent the interests of all regions of Canada. Proposals should demonstrate partnerships, including support from the appropriate provincial/territorial stakeholders, to ensure appropriate uptake and implementation.
Applicants should consider the following questions, when developing their proposal.
Approved proposals will be funded up to a maximum of $250,000 per year, depending on the scope of activities being undertaken. The total amount available for this Call for Proposals is $3.6M until March 31, 2017.
To receive the application package, contact the DSCIF office by emailing DSCIF-FICSA@hc-sc.gc.ca.
If you wish to submit an application, please consult the Guide for Applicants and complete the following elements:
All proposals must be received no later than 4:00 p.m. EDT on August 29, 2014 by email to DSCIF-FICSA@hc-sc.gc.ca. Faxed applications will not be accepted. A complete application includes a signed and dated electronic copy of the proposal Application Form including all attachments (e.g. budget templates, letters of partnership/support, and any other related documents).
Questions about this Call for Proposals should be directed by email to the above email address.
Please note: Health Canada is under no obligation to enter into a funding agreement as a result of this Call for Proposals.